RCC Data from:

Title: Th17 cells contribute to MEK inhibitor and anti-PD-L1 combination therapy resistance in
KRAS/p53 mutant lung cancers

Authors: David H. Peng†,1,2, B. Leticia Rodriguez†,1, Lixia Diao3, Pierre-Olivier Gaudreau1,4,
Joshua Ochieng Kapere1, Jing Wang3, Lauren A. Byers1, Caleb A. Class5, Aparna Padhye1, Jared
J. Fradette1, Laura Gibson1, Limo Chen1, Don. L Gibbons1,6,*

Submitted